Alpine Immune Sciences Announces Participation in March Investor Conferences

Rhea-AI Summary

Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced participation in two major investor conferences in March 2022. The company will engage in fireside chats at Cowen's 42nd Annual Health Care Conference on March 7 at 2:50 p.m. ET, and Oppenheimer's 32nd Annual Healthcare Conference on March 17 at 2:40 p.m. ET. Webcasts will be accessible on their investor relations website, with replays available for 90 days. The company focuses on pioneering immunotherapy treatments for cancer and autoimmune disorders through advanced protein engineering technologies.

Positive

• Participation in two significant investor conferences indicates strong investor engagement.
• Webcasts allow for broader access to company insights and updates.

Negative

• None.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced that members of its management team will participate at the following investor conferences in March 2022:

Cowen's 42nd Annual Health Care Conference
Date: Monday, March 7, 2022
Time: 2:50 p.m. ET/11:50 a.m. PT
Event: Fireside Chat

Oppenheimer 32nd Annual Healthcare Conference
Date: Thursday, March 17, 2022
Time: 2:40 p.m. ET/11:40 a.m. PT
Event: Fireside Chat

Webcasts of the Cowen and Oppenheimer fireside chats will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the fireside chats will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220301005352/en/

Investor Relations

Alex Sharif

Director, Investor Relations and Corporate Development

Alpine Immune Sciences, Inc

206-788-4545

ir@alpineimmunesciences.com

Media Relations

Kelli Perkins

Red House

Kelli@redhousecomms.com

Source: Alpine Immune Sciences, Inc.

FAQ

What dates will Alpine Immune Sciences participate in investor conferences?

Alpine Immune Sciences will participate in conferences on March 7 and March 17, 2022.

What is the focus of Alpine Immune Sciences?

Alpine Immune Sciences focuses on developing immunotherapy treatments for cancer and autoimmune diseases.

Where can I access the webcasts of the investor conferences for ALPN?

The webcasts will be available on the investor relations section of Alpine Immune Sciences' website.

What time will Alpine Immune Sciences' fireside chat at Cowen's conference take place?

The fireside chat at Cowen's conference is scheduled for 2:50 p.m. ET on March 7, 2022.

What time will the Oppenheimer conference fireside chat occur for ALPN?

The Oppenheimer conference fireside chat is scheduled for 2:40 p.m. ET on March 17, 2022.